In today’s economic environment, our customers need analytical tools that help them work much more efficiently, while improving the accuracy of their results
FRANKFURT, Germany--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, extended its leading FT-IR spectrometry platform by introducing the first research-grade FT-IR system designed for simple one-touch operation. The new Thermo Scientific Nicolet iS50 FT-IR spectrometer is one of several innovative products being introduced at ACHEMA to help customers increase laboratory efficiency in markets ranging from pharma and biotech, to chemical and petrochemical, to industrial and applied. These new offerings, along with the company’s comprehensive portfolio of chromatography, mass spectrometry, and environmental analysis technologies, are being showcased within Thermo Scientific booth B7, hall 4.2 at ACHEMA 2012, being held from June 18 - 22 in Frankfurt.
“In today’s economic environment, our customers need analytical tools that help them work much more efficiently, while improving the accuracy of their results,” said Marc N. Casper, president and chief executive officer of Thermo Fisher. “To meet this challenge, a key element of our innovation strategy is to strengthen our core technology platforms, and the new iS50 FT-IR spectrometer is another excellent example. This new product significantly enhances our industry-leading capabilities by providing our customers with a system that greatly simplifies FT-IR analysis to accelerate their results in research or process applications.”
The Nicolet iS™50 spectrometer builds on the company’s industry-leading Magna, Nexus and Nicolet 6700 spectrometry systems. It features purpose-built accessories and integrated software designed to provide all-in-one materials analysis that helps laboratories improve productivity by solving analytical challenges more quickly and easily. When equipped with optional modules, the iS50 system becomes a powerful materials analysis workhorse capable of extracting vast amounts of information from a wide range of samples.
Also during ACHEMA 2012, Thermo Fisher introduced its Thermo Scientific UltiMate 3000 XRS UHPLC system, setting a new standard of flexibility for the UltiMate 3000 UHPLC+ family. The UltiMate 3000 XRS™ leverages the company’s Dionex UHPLC product line to offer increased capabilities in solvent delivery and sample handling for high-throughput laboratories. The large portfolio of detector options further enhances this flexibility across a wide range of applications.
Thermo Fisher also showcased its new high-performance Thermo Scientific TSQ 8000 triple quadrupole GC-MS system, an easy-to-use instrument that enables greater analytical speed, precision and accuracy while saving time and reducing laboratory costs. The TSQ 8000™ is ideal for forensic toxicology and sports doping testing, as well as applied markets such as food and environmental analysis. For food and polymer laboratories, the new Thermo Scientific Process 11 twin-screw extruder is four to five times smaller than competing twin-screw extruders, requires less sample material and reduces analysis time.
For access to all Thermo Fisher product news and photos related to ACHEMA 2012, please visit the online media room at www.thermofisher.com/news.
About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of $12 billion, we have approximately 39,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through three premier brands, Thermo Scientific, Fisher Scientific and Unity™ Lab Services, which offer a unique combination of innovative technologies, convenient purchasing options and a single solution for laboratory operations management. Our products and services help our customers solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity. Visit www.thermofisher.com.
The following constitutes a “Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: This press release contains forward-looking statements that involve a number of risks and uncertainties. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are set forth in the company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2012, under the caption “Risk Factors,” which is on file with the Securities and Exchange Commission and available in the “Investors” section of our website under the heading “SEC Filings.” Important factors that could cause actual results to differ materially from those indicated by forward-looking statements include risks and uncertainties relating to: the need to develop new products and adapt to significant technological change; implementation of strategies for improving growth; general worldwide economic conditions and related uncertainties; dependence on customers' capital spending policies and government funding policies; the effect of exchange rate fluctuations on international operations; the effect of healthcare reform legislation; use and protection of intellectual property; the effect of changes in governmental regulations; and the effect of laws and regulations governing government contracts, as well as the possibility that expected benefits related to the acquisitions of Dionex and Phadia may not materialize as expected. While we may elect to update forward-looking statements at some point in the future, we specifically disclaim any obligation to do so, even if estimates change and, therefore, you should not rely on these forward-looking statements as representing our views as of any date subsequent to today.